Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. 5000211532

Medchemexpress LLC BD-1008 dihydrobromide | 138356-09-9 | MFCD00209903 | 98.1% | 463.08 | C15H24Br2Cl2N2 | 10 MG
SDP

Catalog No. 5000211532
Encompass_Preferred

BD-1008 dihydrobromide is a sigma receptor antagonist provided as a solid for research use. It is intended for in vitro and preclinical pharmacology studies, with characterized purity, molecular weight, and available milligram-scale pack sizes.

  • Provided as a solid suitable for storage and handling in research labs.
  • High reported purity for reliable pharmacological testing.
  • Supplied in small milligram pack sizes to support experimental dosing.
  • Characterized molecular weight and formula facilitate analytical confirmation.
  • Accompanied by safety and handling documentation for laboratory use.

Catalog No. 50-002-11532 Supplier Medchemexpress LLC Supplier No. HY10096610MG
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

BD-1008 dihydrobromide is a sigma receptor antagonist provided as a solid for research use. It is intended for in vitro and preclinical pharmacology studies, with characterized purity, molecular weight, and available milligram-scale pack sizes.

  • Provided as a solid suitable for storage and handling in research labs.
  • High reported purity for reliable pharmacological testing.
  • Supplied in small milligram pack sizes to support experimental dosing.
  • Characterized molecular weight and formula facilitate analytical confirmation.
  • Accompanied by safety and handling documentation for laboratory use.

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.